Brad is a senior managing director in the firm’s strategic advisory practice. He has over 25 years of investment banking experience advising companies in the healthcare industry and is based in Menlo Park. He has advised on many of the most prominent and complex transactions across the pharmaceutical and biotechnology industries, covering the full spectrum of M&A advisory and financings, including equities and debt instruments. Mr. Wolff’s particular expertise is in devising customized solutions to the more challenging issues facing clients, whether in the capital markets or in a strategic advisory context such as M&A, structured partnerships, separation transactions and royalty transactions. Recent notable transactions include the sale of Arena Pharmaceuticals to Pfizer, the sale of Longboard Pharmaceuticals to Lundbeck and the sale of Regulus Therapeutics to Novartis. Prior to joining Evercore, Brad was co-head of the life sciences investment banking team at Citigroup. Earlier in his career, he was head of West Coast life sciences at Bank of America Merrill Lynch. He earned a B.S. from the University of Minnesota’s Carlson School of Management and an MBA from the Anderson School at UCLA.